<DOC>
	<DOCNO>NCT01559727</DOCNO>
	<brief_summary>The purpose study examine efficacy three dose prednisone , glucocorticoid , treatment patient symptomatic heart failure .</brief_summary>
	<brief_title>Dose-comparison Study Prednisone Heart Failure</brief_title>
	<detailed_description>Heart failure lead cause cardiovascular morbidity mortality world . Most patient acute symptomatic heart failure admit fluid overload . Intravenous loop diuretic essential component current treatment patient . Newly emerge evidence show glucocorticoid could potentiate natriuretic peptide ' action upregulating expression natriuretic peptide receptor A ( NPR-A ) kidney , produce potent diuresis . Therefore , investigator design nonblinded , randomize dose comparison study compare efficacy prednisone 15 , 30 60 mg/day patient symptomatic heart failure .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>hospitalize symptomatic heart failure dyspnea rest minimal activity NTproBNP &gt; 1000pg/ml LVEF â‰¤ 40 % condition ( CHF ) could limit use prednisone ; acute decompensated heart failure active myocarditis obstructive restrictive cardiomyopathy cardiac surgery within previous 3 month acute coronary syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>heart failure</keyword>
	<keyword>diuresis</keyword>
	<keyword>prednisone</keyword>
</DOC>